J&J: to present numerous updated data
(CercleFinance.com) - Johnson & Johnson's Janssen Pharmaceuticals has announced that it will present numerous abstracts at the American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA) meetings.
More than 15 oral presentations and over 20 investigator-initiated studies will highlight new data and updates in multiple myeloma, B-cell malignancies, lung cancer, prostate cancer and bladder cancer across the Janssen portfolio.
This will present the depth and breadth of our oncology portfolio and pipeline at ASCO and EHA this year, it said.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
More than 15 oral presentations and over 20 investigator-initiated studies will highlight new data and updates in multiple myeloma, B-cell malignancies, lung cancer, prostate cancer and bladder cancer across the Janssen portfolio.
This will present the depth and breadth of our oncology portfolio and pipeline at ASCO and EHA this year, it said.
Copyright (c) 2023 CercleFinance.com. All rights reserved.